Characteristics | Control contralateral eyes (n = 29) | Treated eyes (n = 33) | p value |
---|---|---|---|
Age (mean ± SD) | 55.18 ± 10.31 | – | – |
Female (N, %) | 26 (78.7) | – | – |
Preoperative BCVA (logMAR) (median, min–max) | 0.09 (0.00–1.60) | 1.90 (1.60–2.0) |  < 0.0001* |
axial length (mm) (median, min–max) | 28.12 (23.21–29.42) | 28.10 (26.42–31.26) | 0.78 |
Follow-up (months, mean ± SD) | – | 27.20 ± 15.82 | – |
TCA (mm2) (mean ± SD) | 0.46 ± 0.09 | 0.36 ± 0.10 | 0.0004* |
LCA (mm2) (mean ± SD) | 0.32 ± 0.06 | 0.19 ± 0.06 | 0.09 |
CVI (%) (mean ± SD) | 71.2 ± 8.50 | 53.6 ± 8.81 |  < 0.0001* |
Choriocapillaris flow area (mm2) | 2.08 ± 0.50 | 1.70 ± 0.51 | 0.0053* |